SARCULATOR vs ASCO
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
SARCULATOR
This medical tool provides physicians with predictive models for retroperitoneal and extremity sarcoma patients. It estimates overall survival and disease-free survival, serving as an informative resource to enhance physician predictive capabilities.
- Predictive models for sarcoma patients
- Estimates 5-year overall survival
- Estimates 5-year disease-free survival
- Estimates 10-year overall survival
- Estimates cumulative incidence of distant metastasis
- Informative tool for physicians
Read full descriptionHide full description
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. Two kinds of predictions are possible: - RPS: 5-year overall survival (OS) and 5-year disease-free survival (DFS) in primary resected retroperitoneal sarcoma (RPS) patients. . - ESTS: 5- and 10-year overall survival (OS) and cumulative incidence of distant metastasis (CCI of DM) in primary resected extremity STS patients.
ASCO
Read full descriptionHide full description
The new ASCO App is a trusted tool for ASCO Members and the oncology community. Get a personalized feed of practice-changing science from JCO Journals tailored to your specialty, streamline your membership, and access professional development tools like ASCO-SEP®—anytime, anywhere. It’s an essential resource designed to save you time while fostering continuous engagement with the global oncology community.
Screenshots
Verdict
The clearest difference is update cadence: ASCO at fortnightly against SARCULATOR's every 6 months. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
SARCULATOR ships an update every 6 months, ASCO fortnightly. Both last shipped on October 24, 2026.
| Parameter | SARCULATOR | ASCO |
|---|---|---|
| Price | Free | Free |
| Rating | 4.3 (3 ratings) — better | — |
| Number of ratings | 3 — better | — |
| Update frequency | Every 6 months | Fortnightly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.0 — better | 16 |
| Further details — not scored | ||
| Size | 29 MB | 87 MB |
| Age rating | 12+ | 17+ |
| Developer | DIGITAL FOREST SRL | American Society of Clinical Oncology |
In-app purchases
SARCULATOR
No in-app purchases
ASCO
No in-app purchases
